Details for New Drug Application (NDA): 088325
✉ Email this page to a colleague
NDA 088325 describes LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, which is a drug marketed by Fresenius Kabi Usa and Hospira and is included in seven NDAs. It is available from seven suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 088325
| Tradename: | LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER |
| Applicant: | Hospira |
| Ingredient: | lidocaine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 088325
| Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 088325
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | lidocaine hydrochloride | INJECTABLE;INJECTION | 088325 | ANDA | Hospira, Inc. | 0409-4275 | 0409-4275-01 | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-4275-01) / 50 mL in 1 VIAL, MULTI-DOSE (0409-4275-16) |
| LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER | lidocaine hydrochloride | INJECTABLE;INJECTION | 088325 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1416 | 51662-1416-1 | 50 mL in 1 VIAL, MULTI-DOSE (51662-1416-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.5% | ||||
| Approval Date: | Jul 31, 1984 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
